PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.809
https://www.valueinhealthjournal.com/article/S1098-3015(11)02371-0/fulltext
Title :
PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02371-0&doi=10.1016/j.jval.2011.08.809
First page :
A380
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
774